CoChat
Sign Up
Cited by 101

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer’s Disease

Dong, Zhiwu, Gu, Hongjun, Guo, Qiang, Liang, Shuang, Xue, Jian, Yao, Feng, Liu, Xianglu, Li, Feifei, Liu, Huiling, Sun, Li, Zhao, Kewen·2021·Molecular Neurobiology
DOI 10.1007/s12035-021-02323-y
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1007/s12035-021-02323-y

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 84

  1. Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P et al (2013) Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207–216 · DOI · Paper page
  2. Oxtoby NP, Young AL, Cash DM, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ, Fox NC et al (2018) Data-driven models of dominantly-inherited Alzheimer’s disease progression. Brain 141:1529–1544 · DOI
  3. Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G et al (2019) Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer’s disease spectrum. Alzheimers Dement 15:644–654 · DOI
  4. Rabinovici GD, Gatsonis C, Apgar C, Chaudhary K, Gareen I, Hanna L, Hendrix J, Hillner BE et al (2019) Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia. JAMA 321:1286–1294 · DOI · Paper page
  5. Park JC, Han SH, Yi D, Byun MS, Lee JH, Jang S, Ko K, Jeon SY et al (2019) Plasma tau/amyloid-beta1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer’s disease. Brain 142:771–786 · DOI
  6. Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, Airey DC, Knopman DS et al (2018) Plasma phospho-tau181 increases with Alzheimer’s disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement 14:989–997 · DOI · Paper page
  7. Gebert LFR, MacRae IJ (2019) Regulation of microRNA function in animals. Nat Rev Mol Cell Biol 20:21–37 · DOI · Paper page
  8. Bartel DP (2018) Metazoan MicroRNAs. Cell 173:20–51 · DOI · Paper page
  9. Dehghani R, Rahmani F, Rezaei N (2018) MicroRNA in Alzheimer’s disease revisited: implications for major neuropathological mechanisms. Rev Neurosci 29:161–182 · DOI
  10. Millan MJ (2017) Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: an integrative review. Prog Neurobiol 156:1–68 · DOI
  11. Song Y, Hu M, Zhang J, Teng ZQ, Chen C (2019) A novel mechanism of synaptic and cognitive impairments mediated via microRNA-30b in Alzheimer’s disease. EBioMedicine 39:409–421 · DOI
  12. Wang X, Liu D, Huang HZ, Wang ZH, Hou TY, Yang X, Pang P, Wei N et al (2018) A novel MicroRNA-124/PTPN1 signal pathway mediates synaptic and memory deficits in Alzheimer’s disease. Biol Psychiatry 83:395–405 · DOI
  13. Idda ML, Munk R, Abdelmohsen K, Gorospe M (2018) Noncoding RNAs in Alzheimer’s disease. Wiley Interdiscip Rev RNA 9:e1463. https://doi.org/10.1002/wrna.1463 · DOI
  14. Wiedrick JT, Phillips JI, Lusardi TA, McFarland TJ, Lind B, Sandau US, Harrington CA, Lapidus JA et al (2019) Validation of microRNA biomarkers for Alzheimer’s disease in human cerebrospinal fluid. J Alzheimers Dis 67:875–891 · DOI
  15. Nagaraj S, Zoltowska KM, Laskowska-Kaszub K, Wojda U (2019) microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancer. Ageing Res Rev 49:125–143 · DOI
  16. Kumar S, Reddy PH (2018) MicroRNA-455-3p as a potential biomarker for Alzheimer’s disease: an update. Front Aging Neurosci 10:41 · DOI
  17. Guo R, Fan G, Zhang J, Wu C, Du Y, Ye H, Li Z, Wang L et al (2017) A 9-microRNA signature in serum serves as a noninvasive biomarker in early diagnosis of Alzheimer’s disease. J Alzheimers Dis 60:1365–1377 · DOI
  18. Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, Liebler DC, Ping J et al (2019) Reassessment of exosome composition. Cell 177(428-445):e18
  19. van Niel G, D’Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19:213–228 · DOI · Paper page
  20. Shah R, Patel T, Freedman JE (2018) Circulating extracellular vesicles in human disease. N Engl J Med 379:958–966 · DOI
  21. Riancho J, Vazquez-Higuera JL, Pozueta A, Lage C, Kazimierczak M, Bravo M, Calero M, Gonalezalez A et al (2017) MicroRNA profile in patients with Alzheimer’s disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples. J Alzheimers Dis 57:483–491 · DOI · Paper page
  22. Gui Y, Liu H, Zhang L, Lv W, Hu X (2015) Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6:37043–37053 · DOI · Paper page
  23. Yang TT, Liu CG, Gao SC, Zhang Y, Wang PC (2018) The serum exosome derived microRNA-135a, -193b, and -384 were potential Alzheimer’s disease biomarkers. Biomed Environ Sci 31:87–96
  24. Liu CG, Song J, Zhang YQ, Wang PC (2014) MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer’s disease. Mol Med Rep 10:2395–2400 · DOI · Paper page
  25. Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR (2015) Plasma exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers. PLoS One 10:e0139233 · DOI · Paper page
  26. Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC et al (2015) Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry 20:1188–1196 · DOI · Paper page
  27. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269 · DOI · Paper page
  28. Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550 · DOI · Paper page
  29. Dweep H, Gretz N (2015) miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods 12:697 · DOI
  30. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408 · DOI · Paper page
  31. Cheng L, Sharples RA, Scicluna BJ, Hill AF (2014) Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 26:eCollection
  32. Moradifard S, Hoseinbeyki M, Ganji SM, Minuchehr Z (2018) Analysis of microRNA and gene expression profiles in Alzheimer’s disease: a meta-analysis approach. Sci Rep 8:4767 · DOI
  33. Liu G, Jiang Y, Wang P, Feng R, Jiang N, Chen X, Song H, Chen Z (2012) Cell adhesion molecules contribute to Alzheimer’s disease: multiple pathway analyses of two genome-wide association studies. J Neurochem 120:190–198 · DOI
  34. Ahmad K, Baig MH, Mushtaq G, Kamal MA, Greig NH, Choi I (2017) Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer disease and other neurodegenerative diseases: an in silico-updated overview. Curr Alzheimer Res 14:1190–1197
  35. Mendes-Silva AP, Pereira KS, Tolentino-Araujo GT, Nicolau Ede S, Silva-Ferreira CM, Teixeira AL, Diniz BS (2016) Shared biologic pathways between Alzheimer disease and major depression: a systematic review of microRNA expression studies. Am J Geriatr Psychiatry 24:903–912 · DOI
  36. Tramutola A, Triani F, Di Domenico F, Barone E, Cai J, Klein JB, Perluigi M, Butterfield DA (2018) Poly-ubiquitin profile in Alzheimer disease brain. Neurobiol Dis 118:129–141 · DOI
  37. Tramutola A, Di Domenico F, Barone E, Perluigi M, Butterfield DA (2016) It is all about (U)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer disease. Oxidative Med Cell Longev 2016:2756068 · DOI
  38. Tai HC, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT (2012) The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol 181:1426–1435 · DOI · Paper page
  39. Tan SH, Karri V, Tay NWR, Chang KH, Ah HY, Ng PQ, Ho HS, Keh HW et al (2019) Emerging pathways to neurodegeneration: dissecting the critical molecular mechanisms in Alzheimer’s disease, Parkinson’s disease. Biomed Pharmacother 111:765–777 · DOI
  40. Barrera-Ocampo A, Arlt S, Matschke J, Hartmann U, Puig B, Ferrer I, Zurbig P, Glatzel M et al (2016) Amyloid-beta precursor protein modulates the sorting of Testican-1 and contributes to its accumulation in brain tissue and cerebrospinal fluid from patients with Alzheimer disease. J Neuropathol Exp Neurol 75:903–916 · DOI
  41. Itzhaki RF, Lathe R, Balin BJ, Ball MJ, Bearer EL, Braak H, Bullido MJ, Carter C et al (2016) Microbes and Alzheimer’s disease. J Alzheimers Dis 51:979–984 · DOI · Paper page
  42. Wozniak MA, Mee AP, Itzhaki RF (2009) Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques. J Pathol 217:131–138 · DOI · Paper page
  43. Waldau B, Shetty AK (2008) Behavior of neural stem cells in the Alzheimer brain. Cell Mol Life Sci 65:2372–2384 · DOI
  44. Wadhwani AR, Affaneh A, Van Gulden S, Kessler JA (2019) Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in Alzheimer disease. Ann Neurol 85:726–739 · DOI · Paper page
  45. Wei H, Xu Y, Xu W, Zhou Q, Chen Q, Yang M, Feng F, Liu Y et al (2018) Serum exosomal miR-223 serves as a potential diagnostic and prognostic biomarker for dementia. Neuroscience 379:167–176 · DOI · Paper page
  46. Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y, Kang L, Liang Y et al (2014) Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. Eur J Cancer 50:1207–1221 · DOI
  47. Pellatt DF, Stevens JR, Wolff RK, Mullany LE, Herrick JS, Samowitz W, Slattery ML (2016) Expression profiles of miRNA subsets distinguish human colorectal carcinoma and normal colonic mucosa. Clin Transl Gastroenterol 7:e152 · DOI
  48. Megiorni F, Cialfi S, McDowell HP, Felsani A, Camero S, Guffanti A, Pizer B, Clerico A et al (2014) Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members. BMC Cancer 14:880 · DOI
  49. Honegger A, Schilling D, Bastian S, Sponagel J, Kuryshev V, Sultmann H, Scheffner M, Hoppe-Seyler K et al (2015) Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog 11:e1004712 · DOI · Paper page
  50. Banerjee S, Karunagaran D (2019) An integrated approach for mining precise RNA-based cervical cancer staging biomarkers. Gene 712:143961 · DOI
  51. Ikeda K, Horie-Inoue K, Ueno T, Suzuki T, Sato W, Shigekawa T, Osaki A, Saeki T et al (2015) miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A. Sci Rep 5:13170 · DOI
  52. Arvidsson Y, Rehammar A, Bergstrom A, Andersson E, Altiparmak G, Sward C, Wangberg B, Kristiansson E et al (2018) miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival. Mod Pathol 31:1302–1317 · DOI
  53. Jahanbani I, Al-Abdallah A, Ali RH, Al-Brahim N, Mojiminiyi O (2018) Discriminatory miRNAs for the management of papillary thyroid carcinoma and noninvasive follicular thyroid neoplasms with papillary-like nuclear features. Thyroid 28:319–327 · DOI
  54. Velazquez-Torres G, Shoshan E, Ivan C, Huang L, Fuentes-Mattei E, Paret H, Kim SJ, Rodriguez-Aguayo C et al (2018) A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression. Nat Commun 9:461 · DOI
  55. Wang M, Sun X, Yang Y, Jiao W (2018) Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p. Thorac Cancer 9:939–949 · DOI
  56. Wang Y, Zhang X, Wang Z, Hu Q, Wu J, Li Y, Ren X, Wu T et al (2018) LncRNA-p23154 promotes the invasion-metastasis potential of oral squamous cell carcinoma by regulating Glut1-mediated glycolysis. Cancer Lett 434:172–183 · DOI
  57. Xu ZH, Yao TZ, Liu W (2018) miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2. Biomed Pharmacother 107:1410–1417 · DOI
  58. Zhu P, Ge N, Liu D, Yang F, Zhang K, Guo J, Liu X, Wang S et al (2018) Preliminary investigation of the function of hsa_circ_0006215 in pancreatic cancer. Oncol Lett 16:603–611
  59. Chen CL, Lin CH, Li AL, Huang CC, Shen BY, Chiang YR, Fang PL, Chang HC et al (2019) Plasma miRNA profile is a biomarker associated with urothelial carcinoma in chronic hemodialysis patients. Am J Physiol Ren Physiol 316:F1094–F1102 · DOI
  60. Fu W, Hong Z, You X, Din J, Chen B, Zhao B, Yuan G, Li Q (2019) Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer. Biomed Pharmacother 118:109374 · DOI
  61. Yang J, Zhang Y, Song H (2019) A disparate role of RP11-424C20.2/UHRF1 axis through control of tumor immune escape in liver hepatocellular carcinoma and thymoma. Aging (Albany NY) 11:6422–6439 · DOI
  62. Cui Y, Xie M, Zhang Z (2020) LINC00958 involves in bladder cancer through sponging miR-378a-3p to elevate IGF1R. Cancer Biother Radiopharm 35:776–788. https://doi.org/10.1089/cbr.2019.3300 · DOI
  63. Zhang C, Wu S (2020) microRNA -378a-3p restrains the proliferation of retinoblastoma cells but promotes apoptosis of retinoblastoma cells via inhibition of FOXG1. Invest Ophthalmol Vis Sci 61:31 · DOI
  64. Greco S, Perfetti A, Fasanaro P, Cardani R, Capogrossi MC, Meola G, Martelli F (2012) Deregulated microRNAs in myotonic dystrophy type 2. PLoS One 7:e39732 · DOI
  65. Siracusa J, Koulmann N, Bourdon S, Goriot ME, Banzet S (2016) Circulating miRNAs as biomarkers of acute muscle damage in rats. Am J Pathol 186:1313–1327 · DOI
  66. Wei X, Li H, Yang J, Hao D, Dong D, Huang Y, Lan X, Plath M et al (2017) Circular RNA profiling reveals an abundant circLMO7 that regulates myoblasts differentiation and survival by sponging miR-378a-3p. Cell Death Dis 8:e3153 · DOI
  67. Wei X, Li H, Zhang B, Li C, Dong D, Lan X, Huang Y, Bai Y et al (2016) miR-378a-3p promotes differentiation and inhibits proliferation of myoblasts by targeting HDAC4 in skeletal muscle development. RNA Biol 13:1300–1309 · DOI
  68. Florian A, Patrascu A, Tremmel R, Rosch S, Sechtem U, Schwab M, Schaeffeler E, Yilmaz A (2018) Identification of cardiomyopathy-associated circulating miRNA biomarkers in muscular dystrophy female carriers using a complementary cardiac imaging and plasma profiling approach. Front Physiol 9:1770 · DOI
  69. Huang N, Wang J, Xie W, Lyu Q, Wu J, He J, Qiu W, Xu N et al (2015) MiR-378a-3p enhances adipogenesis by targeting mitogen-activated protein kinase 1. Biochem Biophys Res Commun 457:37–42 · DOI
  70. Chen W, Zhao W, Yang A, Xu A, Wang H, Cong M, Liu T, Wang P et al (2017) Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis. Gene 636:87–95 · DOI
  71. Hyun J, Wang S, Kim J, Rao KM, Park SY, Chung I, Ha CS, Kim SW et al (2016) MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun 7:10993 · DOI
  72. Caserta S, Mengozzi M, Kern F, Newbury SF, Ghezzi P, Llewelyn MJ (2017) Severity of systemic inflammatory response syndrome affects the blood levels of circulating inflammatory-relevant microRNAs. Front Immunol 8:1977 · DOI
  73. Dubois-Camacho K, Diaz-Jimenez D, De la Fuente M, Quera R, Simian D, Martinez M, Landskron G, Olivares-Morales M et al (2019) Inhibition of miR-378a-3p by inflammation enhances IL-33 levels: a novel mechanism of alarmin modulation in ulcerative colitis. Front Immunol 10:2449 · DOI
  74. Sud N, Zhang H, Pan K, Cheng X, Cui J, Su Q (2017) Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance. J Nutr Biochem 43:125–131 · DOI
  75. Zhang T, Shi H, Liu N, Tian J, Zhao X, Steer CJ, Han Q, Song G (2020) Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis. Theranostics 10:3952–3966 · DOI
  76. Santangelo L, Bordoni V, Montaldo C, Cimini E, Zingoni A, Battistelli C, D’Offizi G, Capobianchi MR et al (2018) Hepatitis C virus direct-acting antivirals therapy impacts on extracellular vesicles microRNAs content and on their immunomodulating properties. Liver Int 38:1741–1750 · DOI
  77. Wang-Renault SF, Boudaoud S, Nocturne G, Roche E, Sigrist N, Daviaud C, Bugge Tinggaard A, Renault V et al (2018) Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjogren’s syndrome. Ann Rheum Dis 77:133–140 · DOI
  78. Muller-Deile J, Dannenberg J, Schroder P, Lin MH, Miner JH, Chen R, Brasen JH, Thum T et al (2017) Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases. Kidney Int 92:836–849 · DOI
  79. Chen T, Wang C, Yu H, Ding M, Zhang C, Lu X, Zhang CY (2019) Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome. EBioMedicine 39:552–561 · DOI
  80. Krist B, Florczyk U, Pietraszek-Gremplewicz K, Jozkowicz A, Dulak J (2015) The role of miR-378a in metabolism, angiogenesis, and muscle biology. Int J Endocrinol 2015:281756 · DOI
  81. Machado IF, Teodoro JS, Palmeira CM, Rolo AP (2020) miR-378a: a new emerging microRNA in metabolism. Cell Mol Life Sci 77:1947–1958 · DOI
  82. Ramanan VK, Saykin AJ (2013) Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer’s disease, Parkinson’s disease, and related disorders. Am J Neurodegener Dis 2:145–175
  83. Ji Q, Wang X, Cai J, Du X, Sun H, Zhang N (2019) MiR-22-3p regulates amyloid beta deposit in mice model of Alzheimer’s disease by targeting mitogen-activated protein kinase 14. Curr Neurovasc Res 16(5):473–480 · DOI
  84. Brennan S, Keon M, Liu B, Su Z, Saksena NK (2019) Panoramic visualization of circulating microRNAs across neurodegenerative diseases in humans. Mol Neurobiol 56(11):7380–7407 · DOI

Cited by

Sorted by citations

See all 101

Metadata

Authors
Dong, Z., Gu, H., Guo, Q., Liang, S., Xue, J., Yao, F., Liu, X., Li, F., Liu, H., Sun, L., & Zhao, K.
ORCID
Dong, Zhiwu
Venue
Molecular Neurobiology
Publisher
Springer Science and Business Media LLC
Published
2021-02-24
Volume
58
Issue
7
Pages
3084-3094
ISSN
  • 0893-7648
  • 1559-1182
DOI
10.1007/s12035-021-02323-y
Cited by
101
References
9
Language
en
Licence
Funders
  • Science and Technology Commission of Shanghai Municipality (19ZR1439300)
  • Shanghai Municipal Health Bureau (201640131)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review